Ta‐Wei Liu

401 total citations
17 papers, 273 citations indexed

About

Ta‐Wei Liu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ta‐Wei Liu has authored 17 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Ta‐Wei Liu's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ta‐Wei Liu is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ta‐Wei Liu collaborates with scholars based in Taiwan, Canada and United States. Ta‐Wei Liu's co-authors include Yanping Zhu, Zarina Madden, David J. Vocadlo, Ih‐Sheng Chen, Hsun‐Shuo Chang, Ming‐Jen Cheng, Sung‐Yuan Hsieh, Gwo‐Fang Yuan, Natasha E. Zachara and Samy Cecioni and has published in prestigious journals such as Journal of the American Chemical Society, Molecules and BMC Genomics.

In The Last Decade

Ta‐Wei Liu

16 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ta‐Wei Liu Taiwan 10 129 73 69 65 52 17 273
Yahya Salma France 10 223 1.7× 44 0.6× 113 1.6× 12 0.2× 101 1.9× 14 404
Guojun Yu China 13 287 2.2× 45 0.6× 36 0.5× 17 0.3× 182 3.5× 16 475
Sulagna Sanyal India 9 185 1.4× 25 0.3× 24 0.3× 9 0.1× 22 0.4× 12 291
Déborah Harrus France 11 184 1.4× 45 0.6× 43 0.6× 63 1.0× 3 0.1× 14 297
Weidi Xiao China 12 303 2.3× 57 0.8× 14 0.2× 16 0.2× 7 0.1× 27 399
Nina Sacerdoti‐Sierra Israel 11 269 2.1× 144 2.0× 121 1.8× 9 0.1× 16 0.3× 12 527
Hao Yin China 13 236 1.8× 12 0.2× 74 1.1× 8 0.1× 44 0.8× 24 403
Joseph Tillotson United States 12 256 2.0× 39 0.5× 33 0.5× 4 0.1× 59 1.1× 20 383
Ravi Rai United States 10 249 1.9× 31 0.4× 123 1.8× 10 0.2× 26 0.5× 16 343

Countries citing papers authored by Ta‐Wei Liu

Since Specialization
Citations

This map shows the geographic impact of Ta‐Wei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ta‐Wei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ta‐Wei Liu more than expected).

Fields of papers citing papers by Ta‐Wei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ta‐Wei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ta‐Wei Liu. The network helps show where Ta‐Wei Liu may publish in the future.

Co-authorship network of co-authors of Ta‐Wei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ta‐Wei Liu. A scholar is included among the top collaborators of Ta‐Wei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ta‐Wei Liu. Ta‐Wei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Iskandar, Benni, et al.. (2024). Herbal nanoemulsions in cosmetic science: A comprehensive review of design, preparation, formulation, and characterization. Journal of Food and Drug Analysis. 32(4). 428–458. 9 indexed citations
2.
Liang, Po‐Cheng, Pei‐Chien Tsai, Po‐Yao Hsu, et al.. (2023). A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic. Journal of Microbiology Immunology and Infection. 56(3). 586–597. 5 indexed citations
3.
Liu, Ta‐Wei, et al.. (2023). Anti-Aging Constituents from Pinus morrisonicola Leaves. Molecules. 28(13). 5063–5063. 1 indexed citations
4.
Liu, Ta‐Wei, Chung‐Feng Huang, Pei‐Chien Tsai, et al.. (2022). The compound annual growth rate of the fibrosis‐4 index in chronic hepatitis B patients. The Kaohsiung Journal of Medical Sciences. 38(7). 686–693.
5.
Jang, Tyng‐Yuan, Yi‐Hung Lin, Po‐Cheng Liang, et al.. (2022). Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. The Kaohsiung Journal of Medical Sciences. 38(9). 897–906. 4 indexed citations
6.
Liu, Ta‐Wei, Chung‐Feng Huang, Ming‐Lun Yeh, et al.. (2020). Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index. BMJ Open Gastroenterology. 7(1). e000543–e000543. 4 indexed citations
7.
Chen, Huimei, Shen‐Chih Wang, Chun Lin Wang, et al.. (2018). Gut microbiome changes in overweight male adults following bowel preparation. BMC Genomics. 19(S10). 904–904. 9 indexed citations
8.
Eskandari, Razieh, David L. Shen, Yanping Zhu, et al.. (2018). Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates. Journal of the American Chemical Society. 140(45). 15300–15308. 40 indexed citations
9.
Yeh, Ming‐Lun, Chung‐Feng Huang, Meng‐Hsuan Hsieh, et al.. (2017). Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals. Journal of Gastroenterology and Hepatology. 32(10). 1754–1762. 48 indexed citations
10.
Tsai, Pei‐Chien, Ta‐Wei Liu, Meng‐Hsuan Hsieh, et al.. (2016). A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan. The Kaohsiung Journal of Medical Sciences. 33(1). 44–49. 9 indexed citations
11.
Chang, Hsun‐Shuo, et al.. (2016). New Metabolites from the Endophytic Fungus Mollisia sp.. Chemistry of Natural Compounds. 52(4). 585–590. 7 indexed citations
12.
Zhu, Yanping, Ta‐Wei Liu, Zarina Madden, et al.. (2015). Post-translationalO-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. Journal of Molecular Cell Biology. 8(1). 2–16. 58 indexed citations
13.
Cheng, Ming‐Jen, Yi Hsiao, Hing‐Yuen Chan, et al.. (2015). Chemical Constituents of the Endophytic Fungus Hypoxylon sp. 12F0687 Isolated from Taiwanese Ilex formosana. Helvetica Chimica Acta. 98(8). 1167–1176. 12 indexed citations
14.
Liu, Ta‐Wei, Ming‐Lun Yeh, Chung‐Feng Huang, et al.. (2014). Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution. The Kaohsiung Journal of Medical Sciences. 31(1). 26–33. 1 indexed citations
15.
Chang, Chun‐Wei, Hsun‐Shuo Chang, Ming‐Jen Cheng, et al.. (2014). Inhibitory Effects of Constituents of an Endophytic Fungus Hypoxylon investiens on Nitric Oxide and Interleukin‐6 Production in RAW264.7 Macrophages. Chemistry & Biodiversity. 11(6). 949–961. 30 indexed citations
16.
Chang, Hsun‐Shuo, Ming‐Jen Cheng, Sung‐Yuan Hsieh, et al.. (2014). Secondary Metabolites from the Endophytic Fungus Xylaria cubensis. Helvetica Chimica Acta. 97(12). 1689–1699. 26 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026